Home› Colorectal Cancer

".....Abstract on FDX-104 in the Treatment of EGFRI induced rash....."

coloCan
coloCan CSN Member Posts: 1,944 Member
May 2016 edited May 2016 in Colorectal Cancer #1

www.einnews.com/pr_news/328675861/foamix-pharmaceuticals-announces-publication-of-abstract-on-fdx-104-in-the-treatment-of-egfri-induced-rash-for-the-2016-asco-meeting

For those so interested, this upcoming ASCO meeting ,aa usual,will have a number of abstracts on CRC; businesswire,for instance,also posted some today,as has asco.org.........

0

Discussion Boards

  • All Discussion Boards
  • 6 CSN Information
  • 6 Welcome to CSN
  • 122.3K Cancer specific
  • 2.8K Anal Cancer
  • 451 Bladder Cancer
  • 310 Bone Cancers
  • 1.6K Brain Cancer
  • 28.5K Breast Cancer
  • 399 Childhood Cancers
  • 27.9K Colorectal Cancer
  • 4.6K Esophageal Cancer
  • 1.2K Gynecological Cancers (other than ovarian and uterine)
  • 13K Head and Neck Cancer
  • 6.4K Kidney Cancer
  • 677 Leukemia
  • 799 Liver Cancer
  • 4.2K Lung Cancer
  • 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
  • 240 Multiple Myeloma
  • 7.2K Ovarian Cancer
  • 65 Pancreatic Cancer
  • 492 Peritoneal Cancer
  • 5.6K Prostate Cancer
  • 1.2K Rare and Other Cancers
  • 544 Sarcoma
  • 740 Skin Cancer
  • 658 Stomach Cancer
  • 192 Testicular Cancer
  • 1.5K Thyroid Cancer
  • 5.9K Uterine/Endometrial Cancer
  • 6.3K Lifestyle Discussion Boards